Novavax COVID-19 vaccine appears 89% effective in UK study
Video Credit: Euronews English - Duration: 02:06s - Published
Novavax COVID-19 vaccine appears 89% effective in UK study
While the Novavax vaccine study is still ongoing, initial results show it is nearly 96% effective against the older coronavirus and nearly 86% effective against the new variant circulating in the UK.
A new intranasal vaccine developed by researchers at the Wuhan lab has recently been unveiled, promising a novel approach to combating infectious diseases. However, this breakthrough has also sparked significant controversy and concern. While the vaccineโs potential to offer a more accessible and efficient method of vaccination is hailed as a major advancement, its origins and the circumstances surrounding its development are raising alarms about a possible new health crisis. Critics worry that the technology used in this vaccine could inadvertently lead to another pandemic-like scenario if not carefully monitored. As the world cautiously watches, the vaccine's rollout is stirring a heated debate about safety, preparedness, and the ethical implications of such advanced biological research.
#IntranasalVaccine #WuhanLab #CovidCrisis #HealthFears #VaccineDebate #PandemicRisk #BioResearch #VaccineDevelopment #PublicHealth #InfectiousDiseases #SafetyConcerns #GlobalHealth #VaccineInnovation #EthicalIssues #HealthSecurity
~HT.97~PR.152~
From Delhi schools opening for Classes 9 and 11 to SII seeking trial approval for the Novavax vaccine, here are the top updates on the pandemic. Delhi government on Friday announced the schools for..
Credit: HT Digital Content Duration: 03:20Published
A fourth coronavirus vaccine could be approved for use in the UK within weeks as late-stage trials suggested it was 89% effective in preventing Covid-19.
The UK has secured 60 million doses of the..